The debt ceiling legislation headed to the president’s desk could stress FDA’s budget, an FDA funding expert warned in a blog post analyzing the high-impact deal. The expert wrote that the deal’s non-defense federal funding cap makes it harder for domestic discretionary programs, like FDA’s budget, to nab funding increases and warns that existing funds for some agencies could be threatened. “This is never a good situation for agencies whose mission and responsibilities keep expanding each year, as is the...